1. ASTA Medica multi dose dry powder inhaler;Berner,1998
2. The relative bioavailability of salbutamol to the lung using urinary excretion following inhalation from a novel dry powder inhaler: the effect of inhalation rate and formulation;Chege;Respir. Med.,2000
3. CPMP, 1995. Note for guidance on clinical requirements for locally applied, locally-acting products containing known constituents. The European Agency for the Evaluation of Medicinal Products, London, United Kingdom.
4. Spirometry in the Lung Health Study. 1. Methods and quality control;Enright;Am. Rev. Respir. Dis.,1991
5. European Pharmacopoeia, 1997a. Preparations for inhalation: aerodynamic assessment of fine particles. Council of Europe, Strasbourg, France, Supplement 2000, pp. 89–99.